Assaying


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
11 Jan 2020
Historique:
received: 13 12 2019
revised: 07 01 2020
accepted: 08 01 2020
entrez: 17 1 2020
pubmed: 17 1 2020
medline: 8 10 2020
Statut: epublish

Résumé

Antibiotic-tolerant persister bacteria involve frequent treatment failures, relapsing infections and the need for extended antibiotic treatment. The virulence of an intracellular human pathogen

Identifiants

pubmed: 31940776
pii: molecules25020294
doi: 10.3390/molecules25020294
pmc: PMC7024427
pii:
doi:

Substances chimiques

Cyclooctanes 0
Lignans 0
Polycyclic Compounds 0
Reactive Oxygen Species 0
dibenzocyclooctadiene lignan 0
Azithromycin 83905-01-5
schizandrin G01BQC0879
Glutathione GAN16C9B8O

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Suomen Kulttuurirahasto
ID : ET and LH

Références

PLoS One. 2016 Jun 09;11(6):e0157306
pubmed: 27280777
Molecules. 2018 Jan 15;23(1):
pubmed: 29342955
Phytochem Rev. 2017;16(2):195-218
pubmed: 28424569
Nature. 2011 Apr 28;472(7344):476-80
pubmed: 21525932
Pathog Dis. 2015 Feb;73(1):1-9
pubmed: 25854002
Nat Prod Commun. 2015 Jun;10(6):1001-4
pubmed: 26197536
Phytother Res. 2015 Sep;29(9):1373-1380
pubmed: 26074330
J Antibiot (Tokyo). 2015 Oct;68(10):609-14
pubmed: 25944533
Free Radic Biol Med. 2010 Dec 15;49(12):1947-55
pubmed: 20888409
J Bacteriol. 2018 Jun 25;200(14):
pubmed: 29735758
Free Radic Biol Med. 2019 Feb 1;131:309-317
pubmed: 30578916
Antimicrob Agents Chemother. 2019 Jul 25;63(8):
pubmed: 31160287
NPJ Biofilms Microbiomes. 2016 Nov 23;2:2
pubmed: 28649396
Toxicology. 2011 Aug 15;286(1-3):48-57
pubmed: 21616119
Infect Immun. 2015 Jul;83(7):2651-60
pubmed: 25895972
Chem Biol Interact. 2015 Apr 25;231:83-9
pubmed: 25753323
Biochem Pharmacol. 2006 Mar 14;71(6):735-41
pubmed: 16414027
PLoS Pathog. 2009 Jan;5(1):e1000284
pubmed: 19158962
Biomed Pharmacother. 2018 Jan;97:958-968
pubmed: 29136774
Expert Opin Drug Discov. 2014 Jul;9(7):791-802
pubmed: 24792993
Nat Rev Microbiol. 2019 Jul;17(7):441-448
pubmed: 30980069
Antimicrob Agents Chemother. 2011 Nov;55(11):5380-3
pubmed: 21844322
Nat Prod Commun. 2016 Nov;11(11):1725-1728
pubmed: 30475517
Arch Microbiol. 1990;154(5):475-82
pubmed: 2256781
J Infect. 2003 Feb;46(2):120-8
pubmed: 12634074
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12147-52
pubmed: 22778419
Front Microbiol. 2018 Dec 12;9:3101
pubmed: 30619180
Free Radic Biol Med. 2010 Dec 1;49(11):1666-73
pubmed: 20807564
Antimicrob Agents Chemother. 2004 Jul;48(7):2659-64
pubmed: 15215123
Biol Pharm Bull. 2010;33(5):825-9
pubmed: 20460761
J Innate Immun. 2019;11(3):216-226
pubmed: 30943492
PLoS One. 2012;7(9):e45778
pubmed: 23029239
Nat Protoc. 2006;1(6):3159-65
pubmed: 17406579
Nature. 2015 Jan 8;517(7533):170-3
pubmed: 25567281
Nature. 2014 May 8;509(7499):235-9
pubmed: 24739962
J Infect Dis. 1990 Sep;162(3):755-8
pubmed: 2387999
Drug Resist Updat. 2018 May;38:12-26
pubmed: 29857815
J Clin Microbiol. 2002 Feb;40(2):575-83
pubmed: 11825973
Immunobiology. 2006;211(5):325-39
pubmed: 16716802
Crit Rev Immunol. 2009;29(4):275-305
pubmed: 19673684
PLoS One. 2012;7(10):e47427
pubmed: 23077614
Respir Res. 2017 May 19;18(1):98
pubmed: 28526018
Ann Otol Rhinol Laryngol. 1998 Jun;107(6):508-13
pubmed: 9635461
Biochem Biophys Res Commun. 2014 Sep 26;452(3):689-94
pubmed: 25193701
Mol Microbiol. 2006 Dec;62(5):1387-401
pubmed: 17059564
Int J Mol Sci. 2014 Dec 30;16(1):724-35
pubmed: 25561227
Free Radic Biol Med. 2003 Aug 15;35(4):368-80
pubmed: 12899939
Immunobiology. 2010 Sep-Oct;215(9-10):842-8
pubmed: 20646782
Bioorg Med Chem. 2010 Apr 1;18(7):2809-15
pubmed: 20236826
Int Endod J. 2018 Apr;51(4):438-447
pubmed: 28898431

Auteurs

Eveliina Taavitsainen (E)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, FI-00014 Helsinki, Finland.

Maarit Kortesoja (M)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, FI-00014 Helsinki, Finland.

Tanja Bruun (T)

Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, FI-00014 Helsinki, Finland.
Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, FI-00014 Helsinki, Finland.

Niklas G Johansson (NG)

Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, FI-00014 Helsinki, Finland.

Leena Hanski (L)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, FI-00014 Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH